Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
98,489,676
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
31,534,174
-
Shares change
-
+271,992
-
Total reported value, excl. options
-
$659,370,855
-
Value change
-
+$8,490,366
-
Number of buys
-
41
-
Number of sells
-
-26
-
Price
-
$20.91
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) as of Q3 2021
84 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q3 2021.
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,534,174 shares
of 98,489,676 outstanding shares and own 32.02% of the company stock.
Largest 10 shareholders include FMR LLC (5,897,652 shares), EcoR1 Capital, LLC (3,468,944 shares), BlackRock Inc. (2,410,542 shares), ORBIMED ADVISORS LLC (2,337,574 shares), VANGUARD GROUP INC (1,598,922 shares), VICTORY CAPITAL MANAGEMENT INC (1,546,323 shares), ArrowMark Colorado Holdings LLC (1,249,707 shares), WELLS FARGO & COMPANY/MN (1,208,769 shares), STATE STREET CORP (1,059,899 shares), and Invus Financial Advisors, LLC (1,007,575 shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.